Nemtabrutinib With Rituximab for the Treatment of Patients With Mantle Cell Lymphoma
Nemtabrutinib With Rituximab for the Treatment of Patients With Mantle Cell Lymphoma
Recruiting · NCT06572618 · Registry updated 2026-03-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Nemtabrutinib With Rituximab for the Treatment of Patients With Mantle Cell Lymphoma | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, mantle cell lymphoma, neoplasm | Recruiting | Phase 2 | 2026-03-13 | NCT06572618 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| City of Hope Medical Center | 347 |
| National Cancer Institute (NCI) | 3015 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| City of Hope at Irvine Lennar | Irvine | United States | 104 |
| City of Hope Medical Center | Duarte | United States | 313 |